Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fennema

Showing results (381-390 of 404) with videos related to

Pageof 41
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthCarol E Franz, Erik Buchholz, Tyler R Bell, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER studyRobert K Heaton, Donald R Franklin, Reena Deutsch, et al.
BMJ (Clinical Research Ed.)|July 7, 2012
Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementationIngrid V F van den Broek, Jan E A M van Bergen, Elfi E H G Brouwers, et al.
Neuroimage|February 17, 2010
Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin studyWilliam S Kremen, Robert C O'Brien, Matthew S Panizzon, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
The New England Journal of Medicine|April 21, 2021
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
Emerging Infectious Diseases|March 23, 2023
Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, IrelandNiamh A Martin, Gabriel Gonzalez, Liam J Reynolds, et al.
Addiction (Abingdon, England)|October 4, 2021
Long-term associations of cigarette smoking in early mid-life with predicted brain aging from mid- to late lifeNathan Whitsel, Chandra A Reynolds, Erik J Buchholz, et al.
Pageof 41

Showing results (381-390 of 404) with videos related to

Sort By:
Pageof 41
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthCarol E Franz, Erik Buchholz, Tyler R Bell, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 2, 2014
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER studyRobert K Heaton, Donald R Franklin, Reena Deutsch, et al.
BMJ (Clinical Research Ed.)|July 7, 2012
Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementationIngrid V F van den Broek, Jan E A M van Bergen, Elfi E H G Brouwers, et al.
Neuroimage|February 17, 2010
Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin studyWilliam S Kremen, Robert C O'Brien, Matthew S Panizzon, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
The New England Journal of Medicine|April 21, 2021
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
Emerging Infectious Diseases|March 23, 2023
Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, IrelandNiamh A Martin, Gabriel Gonzalez, Liam J Reynolds, et al.
Addiction (Abingdon, England)|October 4, 2021
Long-term associations of cigarette smoking in early mid-life with predicted brain aging from mid- to late lifeNathan Whitsel, Chandra A Reynolds, Erik J Buchholz, et al.
Pageof 41